PRNewsWire · BLRX · October 23, 2026

BioLineRx and Hemispherian Present Preclinical Data Demonstrating Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancer at ESMO 2026

Get the app for more

Explore stock news, insights and company research.